ALLO
Allogene Therapeutics, Inc. Healthcare - Biotechnology Investor Relations →
Allogene Therapeutics, Inc. (ALLO) closed at $1.69 as of 2026-02-02, trading 62.2% below its 200-week moving average of $4.47. This places ALLO in the extreme value zone. The stock is currently moving closer to the line, down from -59.2% last week. The 14-week RSI sits at 66, indicating neutral momentum.
Over the past 334 weeks of data, ALLO has crossed below its 200-week moving average 6 times. On average, these episodes lasted 47 weeks. The average one-year return after crossing below was -4.6%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $380 million, ALLO is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -54.4%. The stock trades at 1.2x book value.
Share count has increased 48.8% over three years, indicating dilution.
Over the past 6.5 years, a hypothetical investment of $100 in ALLO would have grown to $6, compared to $256 for the S&P 500. ALLO has returned -34.7% annualized vs 15.6% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: ALLO vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ALLO Crosses Below the Line?
Across 6 historical episodes, buying ALLO when it crossed below its 200-week moving average produced an average return of -17.2% after 12 months (median -3.0%), compared to +17.8% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was -52.0% vs +29.3% for the index.
Each line shows $100 invested at the moment ALLO crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ALLO has crossed below its 200-week MA 6 times with an average 1-year return of +-4.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2019 | Oct 2019 | 4 | 11.1% | +35.9% | -93.8% |
| Nov 2019 | Nov 2019 | 3 | 3.3% | +1.8% | -93.8% |
| Dec 2019 | Apr 2020 | 18 | 30.4% | +1.2% | -93.8% |
| Nov 2020 | Nov 2020 | 1 | 7.5% | -27.6% | -93.9% |
| Dec 2020 | Jan 2021 | 5 | 15.9% | -34.2% | -93.8% |
| May 2021 | Ongoing | 249+ | 86.8% | Ongoing | -94.4% |
| Average | 47 | — | +-4.6% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02